Personalized daily radiation for prostate cancer after surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial studies a “daily adaptive” way of planning and delivering radiation after prostate surgery to treat prostate cancer that is coming back locally. It may help target the tumor more precisely while limiting radiation to healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have prostate cancer that was staged as T2 to T3 and has no nearby lymph node spread, based on the surgery results (pN0).
- You are getting local salvage radiation after prostate surgery, either for early PSA rise (PSA < 0.2) or for PSA that is already 0.2 or higher.
- Your scans show no cancer spread to distant parts of the body (M0) on PSMA-PET-CT.
- You have not had radiation to the same area before.
- You are not being treated with adjuvant (planned after-surgery) radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a radiation plan that is adjusted every day using your own scans to better target prostate cancer. It may help reduce side effects while still treating the cancer effectively in men with lower- or intermediate-risk disease.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial uses a special PET scan to find spots where prostate cancer has spread. Then, it delivers precise radiation to those spots while you receive standard hormone therapy. The goal is to see if this approach helps control the cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.